LTR Pharma Ltd LTP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- A$0.43
- Day Range
- A$0.42–0.44
- 52-Week Range
- A$0.35–0.75
- Bid/Ask
- A$0.43 / A$0.44
- Shares Outstanding
- 182.27M
- Market Cap
- A$80.20M
- Volume/Avg
- 46,457 / 146,109
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 424.48
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
LTR Pharma Ltd is a clinical-stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.ltrpharma.com
Valuation
|
Metric
|
LTP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.86 |
Price/Sales | 424.48 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LTP
|
|---|---|
Quick Ratio | 33.13 |
Current Ratio | 34.36 |
Interest Coverage | — |
Quick Ratio
LTP
Profitability
|
Metric
|
LTP
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
LTP
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|SD?Fpy | LOCK|^FdQ | $140B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|!NV>#R | LOCK|cx^%v | $99B | |||
| Moderna Inc
MRNA
| LOCK|%$k?b$ | LOCK|<rZ | $88B | |||
| argenx SE ADR
ARGX
| LOCK|Vl^XMC | LOCK|j& | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Dgc!r>@ | LOCK|z?< | $43B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|tRRyTs!m | LOCK|^C@<? | $30B | |||
| Incyte Corp
INCY
| LOCK|!<>%v? | LOCK|@D | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|<fmwhRw | LOCK|&v? | $22B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|fB!&Mr | LOCK|$T@vP | $21B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|#yMx#F@ | LOCK|!Q | $15B |
United States